免疫核心 IMCR
$30.99 +$2.59 (+9.12%)
休市 · Nov 7, 5:10 am ET · 最新盘后价 $30.99 0.00%
开盘$29.96
昨收$28.40
当日区间$29.15 – $31.28
成交量1.53M
市值$1.60B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$115.93M+18.3% YoY
营业利润-$3.00M+79.9% YoY
净利润-$808,000.00+92.2% YoY
摊薄每股收益-$0.02+90.0% YoY
自由现金流$15.14M-40.7% YoY
经营现金流$15.93M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率98.9%
营业利润率-5.2%
净利率-4.2%
净资产收益率-4.5%
资产收益率-1.6%
投入资本回报率-2.4%
流动比率4.47
负债/资产比率62.5%
现金及投资$880.21M
总负债$433.05M
净现金（净负债）$447.16M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $115.93M | $106.68M | $400.02M | $104.48M | $103.69M |
| 营业总收入 | $115.93M | $106.68M | $400.02M | $104.48M | $103.69M |
| 营业成本 | $1.09M | $434,000.00 | $5.09M | $2.70M | $513,000.00 |
| 毛利润 | $114.84M | $106.24M | $394.93M | $101.78M | $103.18M |
| 营业费用 | $117.84M | $98.96M | $440.28M | $121.47M | $110.35M |
| 销售及管理费用 | $43.89M | $37.85M | $165.41M | $42.65M | $39.78M |
| 研发费用 | $73.95M | $61.11M | $274.87M | $78.82M | $70.57M |
| 营业利润 | -$3.00M | $7.28M | -$45.35M | -$19.69M | -$7.17M |
| 非经营性利息净收入（支出） | $520,000.00 | $367,000.00 | $4.31M | $853,000.00 | $1.08M |
| 非经营性利息收入 | $3.58M | $3.42M | $16.48M | $3.91M | $4.12M |
| 非经营性利息支出 | $2.52M | $3.05M | $12.17M | $4.62M | $2.52M |
| 其他财务成本合计 | $547,000.00 | – | – | – | $527,000.00 |
| 其他收入（支出） | $1.96M | $5.63M | $21.94M | $3.04M | $6.40M |
| 证券出售收益 | -$1.11M | $3.85M | $2.22M | -$1.46M | $1.33M |
| 其他非经营性收入（支出） | $3.07M | $1.78M | $19.73M | $4.50M | $5.06M |
| 税前利润 | -$514,000.00 | $13.27M | -$19.10M | -$15.79M | $304,000.00 |
| 税费 | $294,000.00 | $301,000.00 | $16.41M | $14.27M | $481,000.00 |
| 净利润 | -$808,000.00 | $12.97M | -$35.51M | -$30.06M | -$177,000.00 |
| 持续经营利润 | -$808,000.00 | $12.97M | -$35.51M | -$30.06M | -$177,000.00 |
| 归属母公司净利润 | -$808,000.00 | $12.97M | -$35.51M | -$30.06M | -$177,000.00 |
| 归属普通股股东净利润 | -$808,000.00 | $12.97M | -$35.51M | -$30.06M | -$177,000.00 |
| 基本每股收益 | -$0.02 | $0.26 | -$0.71 | -$0.60 | $0.00 |
| 摊薄每股收益 | -$0.02 | $0.25 | -$0.71 | -$0.60 | $0.00 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $1.12B | $1.07B | $1.07B | $1.07B | $1.10B |
| 流动资产合计 | $1.05B | $1.00B | $996.74M | $996.74M | $1.02B |
| 现金及现金等价物与短期投资 | $880.21M | $844.90M | $864.15M | $864.15M | $892.35M |
| -现金及现金等价物 | $484.92M | $452.68M | $467.71M | $467.71M | $498.41M |
| -短期投资 | $395.29M | $392.22M | $396.44M | $396.44M | $393.94M |
| 应收款 | $95.35M | $81.07M | $101.12M | $101.12M | $75.88M |
| -应收账款 | $95.35M | $81.07M | $73.98M | $73.98M | $75.88M |
| 存货 | $7.79M | $8.25M | $6.74M | $6.74M | $5.66M |
| 其他流动资产 | $67.69M | $69.59M | $6.75M | $6.75M | $48.96M |
| 非流动资产合计 | $68.38M | $68.29M | $70.53M | $70.53M | $79.65M |
| 固定资产净值 | $49.88M | $49.67M | $50.25M | $50.25M | $48.83M |
| -固定资产原值 | $49.88M | $49.67M | $111.05M | $111.05M | $48.83M |
| 其他非流动资产 | $18.50M | $18.61M | $20.28M | $20.28M | $16.49M |
| 负债合计 | $699.62M | $678.42M | $686.24M | $686.24M | $705.94M |
| 流动负债合计 | $235.20M | $240.11M | $246.70M | $246.70M | $170.35M |
| 应付款 | $26.32M | $30.16M | $24.36M | $24.36M | $22.96M |
| -应付账款 | $26.32M | $30.16M | $24.36M | $24.36M | $22.96M |
| 一年内应计费用 | $197.27M | $202.16M | $203.20M | $203.20M | $134.15M |
| 短期债务及融资租赁负债 | $1.91M | $2.00M | $2.01M | $2.01M | $1.88M |
| -一年内到期融资租赁负债 | $1.91M | $2.00M | $2.01M | $2.01M | $1.88M |
| 一年内递延负债 | $573,000.00 | $572,000.00 | $583,000.00 | $583,000.00 | $582,000.00 |
| 非流动负债合计 | $464.43M | $438.31M | $439.54M | $439.54M | $535.58M |
| 一年以上应计费用 | $26.88M | – | – | – | $96.60M |
| 长期债务及融资租赁负债 | $433.05M | $433.69M | $434.68M | $434.68M | $433.98M |
| -长期债务 | $394.21M | $393.66M | $393.13M | $393.13M | $392.59M |
| -长期融资租赁负债 | $38.85M | $40.03M | $41.56M | $41.56M | $41.40M |
| 一年以上递延负债 | $4.49M | $4.62M | $4.86M | $4.86M | $5.00M |
| 股东权益合计 | $419.80M | $393.67M | $381.03M | $381.03M | $396.56M |
| 股东权益 | $419.80M | $393.67M | $381.03M | $381.03M | $396.56M |
| 股本 | $138,000.00 | $137,000.00 | $136,000.00 | $136,000.00 | $135,000.00 |
| -普通股 | $138,000.00 | $137,000.00 | $136,000.00 | $136,000.00 | $135,000.00 |
| 资本公积 | $1.27B | $1.25B | $1.24B | $1.24B | $1.23B |
| 留存收益 | -$819.11M | -$818.30M | -$831.28M | -$831.28M | -$801.22M |
| 不影响留存收益的损益 | -$34.33M | -$35.37M | -$28.08M | -$28.08M | -$30.01M |
| 其他权益权益 | $1,000.00 | $1,000.00 | $1,000.00 | $1,000.00 | $1,000.00 |
| -应收税款 | – | – | $27.14M | $27.14M | – |
| 预付资产 | – | – | $17.98M | $17.98M | – |
| -累计折旧 | – | – | -$60.80M | -$60.80M | – |
| 一年以上递延资产 | – | – | $0.00 | $0.00 | $14.33M |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | $15.93M | -$13.78M | -$10.71M | -$32.66M | -$4.46M |
| 持续经营经营活动现金流净额 | $15.93M | -$13.78M | -$10.71M | -$32.66M | -$4.46M |
| 持续经营净利润 | -$808,000.00 | $12.97M | -$35.51M | -$30.06M | -$177,000.00 |
| 持续经营损益 | $808,000.00 | -$3.49M | -$6.39M | $3.84M | -$9.62M |
| 折旧、折耗与摊销 | $1.03M | $948,000.00 | $3.27M | $834,000.00 | $798,000.00 |
| 其他非现金项目 | $1.16M | $1.16M | $4.46M | $1.20M | $1.09M |
| 营运资金变动 | $7.41M | -$29.89M | -$9.30M | -$27.10M | -$1.32M |
| -应收款变动 | -$14.62M | -$7.93M | -$7.34M | $1.99M | -$5.99M |
| -预付资产变动 | $2.10M | -$18.77M | -$6.74M | -$1.02M | -$6.09M |
| -应付账款及应计费用变动 | $22.20M | -$2.33M | $13.43M | -$20.61M | $14.85M |
| -其他流动资产变动 | -$755,000.00 | $150,000.00 | -$6.18M | -$4.71M | -$5.00M |
| -其他流动负债变动 | -$1.36M | -$864,000.00 | -$2.09M | -$2.62M | $1.05M |
| -其他营运资金变动 | -$146,000.00 | -$146,000.00 | -$387,000.00 | -$144,000.00 | -$146,000.00 |
| 投资活动现金流净额 | -$786,000.00 | $4.22M | -$16.34M | -$880,000.00 | $5.25M |
| 持续经营投资活动现金流净额 | -$786,000.00 | $4.22M | -$16.34M | -$880,000.00 | $5.25M |
| 固定资产购置及出售净额 | -$786,000.00 | -$1.78M | -$4.34M | -$2.88M | -$748,000.00 |
| 投资购置及出售净额 | $0.00 | $6.00M | -$12.00M | $2.00M | $6.00M |
| 筹资活动现金流 | $16.49M | $656,000.00 | $12.37M | $4.28M | $1.87M |
| 持续经营筹资活动现金流净额 | $16.49M | $656,000.00 | $12.37M | $4.28M | $1.87M |
| 股票期权行使所得 | $16.49M | $656,000.00 | $12.37M | $4.28M | $1.87M |
| 期末现金余额 | $484.92M | $452.68M | $467.71M | $467.71M | $498.41M |
| 现金净变动 | $31.63M | -$8.90M | -$14.68M | -$29.25M | $2.66M |
| 期初现金余额 | $452.68M | $467.71M | $455.73M | $498.41M | $487.93M |
| 汇率变动影响 | $618,000.00 | -$6.13M | $26.66M | -$1.45M | $7.82M |
| 自由现金流 | $15.14M | -$15.56M | -$15.05M | -$35.54M | -$5.20M |
| 递延税款 | – | – | $14.79M | – | – |
| 债务发行及偿还净额 | – | – | $0.00 | $0.00 | – |
| 普通股发行净额 | – | – | $0.00 | – | – |
暂无评论——快来第一个聊聊 IMCR。